Skip to main content
Fig. 9 | BMC Bioinformatics

Fig. 9

From: Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs

Fig. 9

Construction of a prognostic model for COAD based on ncRNA pairs and the drug screening process. Based on gene expression data in FPKM format for COAD in TCGA, we screened eight prognosis-related ncRNA pairs, established a prognostic model risk score using cox and lasso, assessed the superiority of the model and analysed the functional differences between model subgroups. Among 138 drugs screened for potential use in the treatment of high-risk COAD and subjected to CCK-8 cellular assays, an individualised nomogram model was finally developed for clinical decision making

Back to article page